The results reveal that RT-activated Sirpα-deficient phagocytes function less as enhanced phagocytes toward tumor cells, but more so as proinflammatory initiators and adept antigen-presenting cells (APC), which conduct immunogenic antigen presentation in situ to robustly activate tumor-specific memory T cells and Tc cytotoxicity. The gene discussed is SIRPA; the disease is neoplasm.